Kynurenic acid content in anti-rheumatic herbs

Annals of Agricultural and Environmental Medicine

Volumn 20, Issue 4, 2013, Pages 800-802

  Zgrajka, Wojciech ^a   Turska, Monika ^b   Rajtar, Grazyna ^b   Majdan, Maria ^b   Parada Turska, Jolanta ^b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arthritis; Herb; Kynurenic acid

Indexed keywords

ANTIRHEUMATIC AGENT; HERBACEOUS AGENT; KYNURENIC ACID; PEPPERMINT;

ARTICLE; BARK; BEAN; BIRCH; DANDELION; DRUG DETERMINATION; DRUG MIXTURE; EQUISETUM; FLOWER; FLUOROMETRY; HARPAGOPHYTUM; HERB; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NETTLE; NONHUMAN; PERICARP; PLANT LEAF; PLANT ROOT; RHEUMATIC DISEASE; TEA; WILLOW;

HUMANS; KYNURENIC ACID; PLANT PREPARATIONS; PLANTS, MEDICINAL; RHEUMATIC DISEASES;

EID: 84891133683     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci. 2001; 21: 7463-7473.
2. Albuquerque EX, Schwarcz R. Kynurenic acid as an Antagonist of alpha7 Nicotinic Acetylcholine Receptors in the Brain: Facts and Challenges. Biochem Pharmacol. 2012; 85: 1027-32.
3. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem. 2006; 281: 22021-22028.
4. Kaszaki J, Palasthy Z, Erczes D, Racz A, Torday C, Varga G, et al. Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil. 2008; 21: 53-62.
5. Varga G, Erces D, Fazekas B, Fulop M, Kovacs T, Kaszaki J, et al. N-Methyl-d-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat. Neurogastroenterol Motil. 2010; 22: 217-225.
6. Lugo-Huitron R, Blanco-Ayala T, Ugalde-Muniz P, Carrillo-Mora P, Pedraza-Chaverri J, Silva-Adaya D, et al. On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress. Neurotoxicol Teratol. 2011; 33: 538-547.
7. Moroni F, Cozzi A, Sili M, Mannaioni G. Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. J Neural Transm. 2012; 119: 133-139.
8. Igari T, Tsuchizawa M. Tryptophan metabolism in the synovial fluid in rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med. 1969; 99: 73-80.
9. Zgrajka W, Turska M, Rajtar G, Majdan M, Parada-Turska J. Kynurenic acid in synovial fluid and serum of patients with rheumatoid arthritis, spondyloarthropathy and osteoarthritis. J Rheumatol. 2013; in press.
10. World Health Organization (WHO). WHO Medicine Strategy 2002-2005, Geneva: WHO. 2002.
11. World Health Organization (WHO). Traditional Medicine Fact sheet No 134., 2008: Retrieved from: www. who. int/mediacentre/factsheets/fs134/en/.
12. Turski MP, Turska M, Zgrajka W, Kuc D, Turski WA. Presence of kynurenic acid in food and honeybee products. Amino Acids. 2009; 36: 75-80.
13. Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer-Szerszen M, Turski W. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int. 2006; 26: 422-426.
14. Turski MP, Turska M, Zgrajka W, Bartnik M, Kocki T, Turski WA. Distribution, synthesis, and absorption of kynurenic acid in plants. Planta Med. 2011; 77: 858-864.